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Abstract
Background:  Unlike mouse immature bone marrow (BM)-derived dendritic cells (DC), rat
immature BMDC have not been thoroughly characterised in vitro for the mechanisms underlying
their suppressive effect. To better characterise these mechanisms we therefore analysed the
phenotypes and immune inhibitory properties of rat BMDC generated with GM-CSF plus IL-4 (=
IL-4 DC) and with GM-CSF plus IL-10 (= IL-10 DC).
Results: Both IL-4 DC and IL-10 DC exhibited lower surface expression of MHC class II and
costimulatory molecules than mature splenic DC. They had a strong inhibitory effect on responsive
T cells in vitro and despite their weak function as antigen-presenting cells they induced anergic T
cells. However, only anergic T cells induced by IL-4 DC had a suppressive effect on responsive T
cells. Induction of suppressive/tolerogenic T cells by IL-4 DC required direct contact between
antigen-specific T cells and IL-4 DC. In addition, IL-4 DC and IL-10 DC prolonged allograft survival
in an antigen-specific manner.
Conclusion:  A unique phenotype of immature BMDC was isolated from the cultures. The
mechanisms underlying the suppressive effect may be caused by their inability to deliver adequate
costimulatory signals for T-cell activation. In addition, IL-4 DC but not IL-10 DC induce anergic T
cells with suppressive function. This indicates that IL-4 DC and IL-10 DC may differ in the quality
of their costimulation although no differences in the surface expression of costimulatory molecules
were found.
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Background
In recent years it has become clear that dendritic cells
(DC) are not only potent inducers of adaptive immune
responses, but also essential mediators in the induction
and maintenance of T-cell tolerance [1]. The biological
properties of DC depend on their phenotypically distinct
states of development [2]. Their delaying effect on allo-
graft rejection has been demonstrated in several rodent
models [reviewed in [3]].
Mouse and human DC have both been studied thor-
oughly [reviewed in [4]]. Rat DC have been investigated
particularly by groups interested in transplantation
research [5-7]. They were not studied thoroughly,
although established culture methods exist for the gener-
ation of bone marrow-derived rat DC (BMDC) [8,9]. The
maturation of BMDC varies from species to species
despite comparable culture conditions. In mice, for exam-
ple, low doses of granulocyte macrophage colony stimu-
lating factor (GM-CSF) combined with interleukin (IL)-4
induce the formation of mature BMDC [10], whereas in
rats the same combination produces immature BMDC
[11]. The effect of GM-CSF and IL-10 on the generation of
rat BMDC is not clearly known.
In the present study we examined the ability of IL-4 DC
and IL-10 DC to inhibit both the activation of naïve T cells
and the restimulation of antigen-specific T cells in vitro.
We also analysed their in vivo potential to prolong allo-
graft survival.
Methods
Generation of rat BMDC
Femur and tibia bones of young (8–10 weeks) Lewis rats
were extracted and disinfected in 70% ethanol. Both ends
of the bones were cut and the bone marrow (BM) cells
were flushed with 20 ml phosphate-buffered saline (PBS).
The BM cells were cultured at a cell density of 5–8 × 105
cells/ml in culture dishes (Falcon, Becton Dickinson Bio-
sciences). The RPMI 1640 culture medium [12] was sup-
plemented with 5 ng/ml recombinant rat GM-CSF (R&D
Systems, Heidelberg, Germany) and 5 ng/ml recombinant
rat IL-4 (Miltenyi Biotech GmbH, Germany) or 5 ng/ml
rat IL-10 (Miltenyi Biotech GmbH). On day 6, non-adher-
ent cells and cells growing in clusters were collected.
Cell isolation
Splenic DC (S-DC), naïve and antigen-specific T cells were
isolated from Lewis rats as described previously [12].
Allopeptide P1-specific T cells were induced by immuni-
zation with P1 [12].
Activation of naïve T cells and restimulation of antigen-
specific T cells
Naïve T cells (105 cells/well) were incubated with 20 Gy
irradiated IL-4 DC, IL-10 DC, or mature S-DC (104 cells/
well) for 3 days at 37°C in a 5% humidified CO2 atmos-
phere. Allopeptide P1-specific T cells (105 cells/well) were
incubated with irradiated (20 Gy) IL-4 DC, IL-10 DC, or
S-DC (104 cells/well) loaded with P1 (1.25 μg/well) for 3
days at 37°C in a 5% humidified CO2 atmosphere. T-cell
proliferation in 96-well, round-bottom plates was meas-
ured after 3H-thymidine (0.5 μCi/well) incubation for the
last 6 h before harvesting. Radioactivity was determined as
previously described [12]. Results (mean ± SD) were
expressed in counts per minutes (cpm).
Transwell experiments
Some of the assays were performed in 96-well transwell
plates (Corning Life Sciences, The Netherlands). The
upper compartment contained immature rat BMDC (1 ×
104), the lower compartment antigen-specific T cells (1 ×
105). After 3 days of culture, the transwells were removed
and P1-loaded S-DC (104/well) as well as antigen-specific
T cells (1 × 105/well) were added to the lower compart-
ments. The cultures were then incubated for another 3
days and pulsed with 0.5 μCi/well [3H]-thymidine for the
last 6 h of culture. The incorporation of [3H]-thymidine
was measured as described [12].
Morphology and immunostaining of IL-4 DC and IL-10 DC Figure 1
Morphology and immunostaining of IL-4 DC and IL-
10 DC. Rat BMDC were isolated from cell clusters on day 6 
of culture (A). Cells prepared on cytospin slides stained posi-
tive for monoclonal antibodies Ox62 (rat DC marker) (B), 
Ox6 (MHC class II) (C), and CD68 (D). Shown are repre-
sentative IL-4 DC results, which are similar to those for IL-10 
DC. Magnification: ×200 (A, C, D) and ×400 (B).
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Heterotopic heart transplantation with and without 
antigen-loaded BMDC
The animal experiments were conducted in accordance
with European, national and institutional animal care
policies. Ten million BMDC were incubated with 20 μg P1
for 30 min in 500 μl PBS, washed 2 times with PBS and
transferred intravenously via the penile vein into Lewis
rats under full anesthesia with isoflurane 1 day before
transplantation. Fully vascularised, heterotopic heart
transplantation was performed, and graft survival was
monitored as described [12].
Results
IL-4 DC and IL-10 DC exhibited an identical phenotype
On approximately day 3 of culture low adherent cell clus-
ters were obvious and both the number and size of the
clusters increased during culture (Fig. 1A). The BMDC iso-
lated from these clusters on day 6 were positive for Ox62
(a marker for rat DC), Ox6 (anti-MHC class II), and the
macrophage marker ED1 (CD68) (Fig. 1B–D). More than
77% of the cells isolated from the clusters were double
positive for Ox62 and Ox6 without further purification.
The flow cytometric analysis revealed that IL-4 DC and IL-
10 DC expressed MHC II and the costimulatory molecules
CD40, CD80 and CD86 at nearly identical levels on their
surface (Fig. 2).
IL-4 DC and IL-10 DC neither activated naïve T cells nor 
restimulated antigen-specific T cells
Naïve T cells did not proliferate in the presence of IL-4 DC
and IL-10 DC, whereas mature S-DC induced a strong T-
cell proliferation (Fig. 3A). IL-4 DC and IL-10 DC loaded
with the allogeneic peptide P1 [12] were not able to res-
timulate P1-specific T cells (Fig. 3B). Different numbers
(103, 104 and 105) of P1-loaded IL-4 DC or IL-10 DC sup-
pressed the proliferation of antigen-specific T cells
induced by P1-pulsed S-DC (Fig. 3C, D). For both BMDC
types, IL-12-specific mRNA was not detectable by RT-PCR
(Additional File 1, Table 1). This may indicate that they
revealed properties of immature DC.
In the BMDC-uninfluenced T-cell proliferation assay, the
strongest increase in proliferation of antigen-specific T
cells occurred between days 2 and 3 of the 3-day culture.
IL-4 DC and IL-10 DC exhibit no obvious differences in their phenotype Figure 2
IL-4 DC and IL-10 DC exhibit no obvious differences in their phenotype. IL-4 DC and IL-10 DC and mature splenic 
DC (sDC) coexpressed Ox62 and CD68, whereas macrophages generated in the presence of M-CSF (5 μg/ml) were only pos-
itive for CD68. Broken lines indicate background staining obtained using an irrelevant isotype control. The first number repre-
sents the percentage of cells staining positive for the indicated marker and the second number represents the mean 
fluorescence intensity. The results shown are representative for 4 independent flow cytometric analyses. The antibodies were 
purchased from Serotec, Ltd, Oxford, United Kingdom, with the exception of HM40-3 and 24F (BD Biosciences, Heidelberg, 
Germany).
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The addition of P1-pulsed IL-4 DC or IL-10 DC to the cul-
tures on day 2 halted this strong increase in T-cell prolif-
eration within 24 h (Fig. 3E, F).
IL-4 DC-T and IL-10 DC-T showed anergic properties
P1-specific T cells were named IL-4 DC-T when incubated
with IL-4 DC and IL-10 DC-T when incubated with IL-10
DC. Following purification, the DC-T were transferred to
104 P1-pulsed mature S-DC and their proliferation rate
after 72 h was low (Fig. 4). The anergic-like effect of IL-4
DC-T and IL-10 DC-T could be negated by adding exoge-
nous IL-2 (27 ng/ml) to the cultures (Fig. 4).
IL-4 DC-T had an inhibitory effect on antigen-specific T 
cells
Different numbers (103, 104 and 105) of IL-4 DC-T were
added to assays containing P1-loaded S-DC and freshly
isolated antigen-specific T cells. Measurement of prolifer-
ation revealed that IL-4 DC-T had a dose-dependent
inhibitory effect on T-cell proliferation (Fig. 5A). Antigen-
specific T cells cultured with IL-4 DC-T in transwell plates
did not reduce the control T-cell proliferation (Fig. 5B).
Antigen-specific T cells must have direct contact with IL-4
DC in precultures to have an inhibitory effect on T-cell
proliferation in second cultures. The IL-10 DC-T, in con-
IL-4 DC and IL-10 DC inhibit the proliferation of responsive T cells Figure 3
IL-4 DC and IL-10 DC inhibit the proliferation of responsive T cells. IL-4 DC and IL-10 DC were unable to activate 
either naïve T cells in the mixed leukocytes culture (A) or antigen-specific T cells in the T-cell proliferation assay (B). The effect 
of mature S-DC on the proliferation of naïve T cells is shown in the inset of Fig. A. The antigen-specific restimulation of P1-spe-
cific T cells by P1-loaded S-DC (P1) is shown in B (inset). Different numbers of IL-4 DC and IL-10 DC influenced the S-DC-
induced proliferation of antigen-specific T cells (C-D). The addition of P1-loaded IL-4 DC and IL-10 DC to the proliferation 
assay on day 2 of the 3-day culture prevented the marked increase in T-cell proliferation that had been induced by P1-loaded S-
DC between days 2 and 3 (E-F). The results (mean ± standard deviation) shown are representative for 3 different experiments. 
Control: Naïve T cells (A) and antigen-specific T cells (B) cultured alone; ∅: P1-unloaded S-DC.
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trast, had no influence on the proliferation of antigen-spe-
cific T cells (not shown).
P1-loaded IL-4 DC and IL-10 DC prolonged antigen-
specific cardiac allograft survival
Ten million of P1-loaded BMDC administered intrave-
nously to each Lewis rat 1 day before they received heart
allografts let them survive 2 days longer than those ani-
mals transfused with unpulsed BMDC, which had no
effect on allograft survival (Table 2 and Fig. 6). The sur-
vival of allografts from third party donors (Brown-Nor-
way rats) was not affected by the transfer of P1-pulsed IL-
4 DC and IL-10 DC (Table 2).
Discussion
In the present study, we compared the effects of 2 types of
rat BMDC on the proliferation of naïve and antigen-spe-
cific T cells in vitro and on the survival of allogeneic heart
allografts. Both DC types displayed lower surface expres-
sion of MHC class II and costimulatory molecules com-
pared to mature splenic DC. IL-4 DC and IL-10 DC had a
strong inhibitory effect on responsive T cells. This sup-
pressive effect was detectable within 24 h after the BMDC
were added to cultures with antigen-specific T cells and
mature splenic DC (Fig. 3E, F). To our knowledge this is
the first description of the time course BMDC needed to
suppress T-cell proliferation. We found that antigen-spe-
cific T cells became anergic after incubation with IL-4 DC
and IL-10 DC. The same effect has been described for
human IL-10 modified DC on CD4+ T cells [13]. Anergic
T cells isolated from cultures with P1-loaded IL-4 DC sup-
pressed the DC-mediated activation of responsive T cells
in a cell count-dependent manner. They share this sup-
pressive effect with regulatory T cells [14]. We hypothesise
that IL-4 DC and IL-10 DC may differ in the quality of
their costimulation, with IL-4 DC inducing suppressive IL-
4 DC-T whereas IL-10 DC do not. It should be empha-
sised, however, that we found no differences in the surface
IL-4 DC-T and IL-10 DC-T do not proliferate and demon- strate anergy Figure 4
IL-4 DC-T and IL-10 DC-T do not proliferate and 
demonstrate anergy. IL-4 DC-T and IL-10 DC-T, purified 
and transferred to second cultures, did not proliferate in 
response to subsequent stimulation with P1-loaded splenic 
DC (S-DC), but required the addition of IL-2 (B). In contrast, 
antigen-specific T cells not precultured with IL-4 DC or IL-10 
DC had proliferation rates of 35,200 ± 5,100 cpm (not 
shown). The results (mean ± standard deviation) are repre-
sentative for 3 different experiments.
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Table 1: Primers and PCR conditions.
Primer Sequence (5'- > 3') PCR product Annealing temperature
GAPDH For: GGT CGG TGT GAA CGG ATT TG
Rev: GTG AGC CCC AGC CTT CTC CAT
319 bp 62°C
MHC II For: CAG GAT CTG GAA GGT CCA
Rev: AGC TGT GGT TGT GCT GA
517 bp 55°C
CD40 For: CGC TAT GGG GCT GCT TGT TGA CAG;
Rev: GAC GGT ATC AGT GGT CTC AGT GGC
401 bp 58°C
CD80 For: TGG TGA AAC ACC TGA CCA
Rev: GTT TCT CTG CTT GCC TCA
517 bp 50°C
CD86 For: TGG GAA ACA GAG CTC TCA
Rev: AGG TTG ATC GAC TCG TCA
518 bp 53°C
Primers specific for rat IL-12p35 was purchased from Invitrogen/Biosource. Total RNA was isolated from 106 cells with 1 ml of the ready-to-use 
reagent Trizol Reagent (Invitrogen GmbH, Germany) according to the manufacturer's recommendations. Reverse transcription of 5 μl RNA was 
performed using the GeneAmp RNA-PCR-Kit (Applied Biosystems GmbH, Germany). Five μl cDNA was amplified using Gold AmpliTaq DNA-
Polymerase (0.05 U/μl) and the specific primers (5 μmol/L each) mixed in nuclease free water (Promega GmbH, Germany) to an end volume of 50 
μl per sample.BMC Research Notes 2009, 2:12 http://www.biomedcentral.com/1756-0500/2/12
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expression of costimulatory molecules between the two
BMDC types.
The results of transwell experiments showed that the con-
tact between IL-4 DC and the antigen-specific T cells is a
prerequisite for inducing suppressive IL-4 DC-T. However,
we made no attempt in this study to determine whether
the anergic IL-4 DC-T mediate their suppressive effect via
cell-cell contact or by soluble factors. Vendetti et al., for
example, reported that inhibition mediated by anergic
murine T cells is dependent on cell-cell contact [15]. They
also described an inhibitory effect of anergic T cells on the
antigen-presenting function of mature DC.
IL-4 DC and IL-10 DC, loaded with allopeptide P1, pro-
longed allograft survival (Fig. 6). In addition, survival
time can be improved by increasing the number of trans-
ferred cells. The application of 30 million P1-pulsed IL-10
DC, for example, prolonged survival time to a median of
10.6 ± 0.8 days (not shown) from the 9.5 ± 0.8 days
achieved with 10 million P1-pulsed IL-10 DC. Allograft
survival was prolonged only when the BMDC were pulsed
with the immunodominant allogeneic peptide P1
involved in allograft rejection [5]. Our results accord with
those of Chowdhury et al. [16], who showed that the pres-
entation of allogeneic peptides by tolerogenic thymic rat
DC greatly prolongs allograft survival. Compared to the
results of Chowdhury et al., our 2–3 day prolongation of
allograft survival may seem meager, but considering the
strength of the allogeneic immune response induced by
alloreactive T cells and the fact that no immunosuppres-
sive drugs were used, our findings appear very promising.
Conclusion
The data suggest that rat IL-4 DC and IL-10 DC have sup-
pressive/regulatory properties comparable to those
described for immature mice BMDC. They demonstrate a
strong inhibitory effect on responsive T cells, probably the
consequence of a reduced surface expression of costimu-
latory molecules paired with the inability to deliver ade-
quate costimulatory signals to T cells. IL-4 DC and IL-10
DC are identical in phenotype and in some of their effects,
but they are different in their capacity to induce suppres-
sive T cells. IL-4 DC induce T cells with suppressive/regu-
latory function whereas IL-10 DC do not. This may
indicate that IL-4 DC and IL-10 DC differ in the quality of
IL-4 DC-T inhibit the proliferation of antigen-specific T cells in a dose-dependent manner Figure 5
IL-4 DC-T inhibit the proliferation of antigen-specific T cells in a dose-dependent manner. Different numbers of 
IL-4 DC-T which were in contact with IL-4 DC during the first culture (without transwell) were added to the proliferation 
assay containing freshly isolated P1-specific T cells and P1-loaded S-DC. The IL-4 DC-T inhibited their restimulation in a cell 
number dependent manner (A). Antigen-specific T cells which were not in contact with IL-4 DC during the first culture (tran-
swell experiment) had no inhibitory effect (B). The results (mean ± standard deviation) are representative for 3 different 
experiments.
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their costimulation. Further studies are necessary to test
this hypothesis.
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The in vivo effect of P1-loaded IL-4 DC and IL-10 DC Figure 6
The in vivo effect of P1-loaded IL-4 DC and IL-10 DC. P1-loaded IL-4 DC and IL-10 DC prolonged the survival of alloge-
neic hearts grafts from Wistar-Furth in Lewis recipients. In contrast, unpulsed IL-4 DC and IL-10 DC did not influence allograft 
survival. The allogeneic control group I demonstrates the natural rejection of Wistar-Furth allografts by Lewis recipients (see 
also Table 2).
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